Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

References

• Arthritis Foundation. Arthritis Foundation survey on NSAID ulcer prevention. Westport, CT: Yankelovich, Skelly, White/Clancy, Shulman, 1989.
   Google Scholar
• Larkai EN, Smith JL, Lidsky MD, et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987: 82(11): 1153–8
   PubMed Web of Science ®Google Scholar
• Coles LS, Fries JF, Kraines RG, et al. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med 1983: 74(5): 820–8
   PubMed Web of Science ®Google Scholar
• O'Laughlin JC, Hoftiezer JW, Ivey KJ. Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration. Scand J Gastroenterol (Suppl) 1981: 67: 211–4
   PubMedGoogle Scholar
• Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986: 104(3): 390–8
   PubMed Web of Science ®Google Scholar
• Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983: 28(1): 1–6
   PubMed Web of Science ®Google Scholar
• Wu WC, Semble EL, Castell DO, et al. Sucralfate therapy of nonsteroidal anti-inflammatory drug induced gastritis. (Abstr) Gastroenterology 1985: 88(5 Pt 2): 1636
   Web of Science ®Google Scholar
• Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987: 28(5): 527–32
   PubMed Web of Science ®Google Scholar
• Cameron AJ. Aspirin and gastric ulcer. Mayo Clin Proc 1975: 50(10): 565–70
   PubMed Web of Science ®Google Scholar
• Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979: 91(4): 517–20
   PubMed Web of Science ®Google Scholar
• Caruso I, Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. BMJ 1980: 280(6207): 75–8
   PubMedGoogle Scholar
• Lockard OO Jr, Ivey KJ, Butt JH, et al. The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy. Gastrointest Endosc 1980: 26(1): 5–7
   PubMed Web of Science ®Google Scholar
• Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 1990: 300(6720): 278–84 [erratum, BMJ 1990: 300(6727): 764]
   PubMed Web of Science ®Google Scholar
• Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988: 2(8623): 1277–80
   PubMed Web of Science ®Google Scholar
• Ehsanullah RS, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988: 297(6655): 1017–21
   PubMed Web of Science ®Google Scholar
• FDC Report. 1987 Nov 29: 8–9
   Google Scholar
• Fries JF, Miller SR, Spitz PW, et al. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 1989: 96(2 Pt 2 Suppl): 647–55
   PubMed Web of Science ®Google Scholar
• Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988: 109(5): 359–63
   PubMed Web of Science ®Google Scholar
• Kurata JH, Abbey DE. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990: 12(3): 260–6
   PubMed Web of Science ®Google Scholar
• Elliot SL, Yeomans ND, Buchanan RR. Long-term effects of misoprostol on gastropathy induced by nonsteroidal anti-inflammatory drugs (NSAID). (Abstr) Gastroenterology 1990: 98 (5 Suppl): A40
   Google Scholar
• Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991: 114: 257–63
   PubMed Web of Science ®Google Scholar
• Wilson DE. Antisecretory and mucosal protective actions of misoprostol: potential role in the treatment of peptic ulcer disease. Am J Med 1987: 83(1A): 2–8
   PubMed Web of Science ®Google Scholar
• Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979: 77(4 Pt 1): 761–7
   PubMed Web of Science ®Google Scholar
• Miller TA Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983: 245(5 Pt 1): G601–23
   PubMed Web of Science ®Google Scholar
• Soll AH, Weinstein WM, Kurata J, et al. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991: 114(4): 307–19
   PubMed Web of Science ®Google Scholar
• Laine L, Marin-Sorensen M, Weinstein WM. Is Campylobacter pylori (CP) prevalence lower in gastric ulcers (GU's) because of nonsteroidal antiinflammatory drug (NSAID) use? A prospective evaluation. (Abstr) Gastroenterology 1989: 96(5 Suppl): A282
   Google Scholar
• McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 1989: 96(2 Pt 2 Suppl): 662–74
   PubMed Web of Science ®Google Scholar
• Kimmey MB, Silverstein FE, Saunders DR, et al. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. Dig Dis Sci 1987: 32(8): 851–6
   PubMed Web of Science ®Google Scholar
• Agrawal NM, Stromatt S, Brown J. Comparison of misoprostol and sucralfate in prevention of NSAID-induced gastric ulcer. (Abstr) Gastroenterology 1990: 98(5 Suppl): A14
   Google Scholar
• Roth S, Agrawal N, Mahowald M, et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989: 149(4): 775–9
   PubMedGoogle Scholar
• Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989: 320(2): 69–75
   PubMed Web of Science ®Google Scholar